miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
about
S100β as a serum marker in endocrine resistant breast cancer.miR-548d-3p/TP53BP2 axis regulates the proliferation and apoptosis of breast cancer cells.A new avenue for obtaining insight into the functional characteristics of long noncoding RNAs associated with estrogen receptor signaling.Distinct prognostic values of S100 mRNA expression in breast cancer.Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
P2860
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@ast
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@en
type
label
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@ast
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@en
prefLabel
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@ast
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@en
P2093
P2860
P1433
P1476
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
@en
P2093
Akaansha Ganju
Amita Sneh
Helong Zhao
Mohd W Nasser
Mustafa Basree
Ramesh K Ganju
Tasha Wilkie
Yadwinder Deol
P2860
P2888
P356
10.1186/S12943-014-0275-Z
P577
2015-01-27T00:00:00Z
P5875
P6179
1045650080